PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
+6.3%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$4.65B
AUM Growth
+$4.65B
(+18%)
Cap. Flow
+$677M
Cap. Flow
% of AUM
14.56%
Top 10 Holdings %
Top 10 Hldgs %
32.67%
Holding
106
New
23
Increased
28
Reduced
31
Closed
10
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$198M |
| 2 |
Viatris
VTRS
|
$190M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$171M |
| 4 |
Elevance Health
ELV
|
$86.4M |
| 5 |
Tenet Healthcare
THC
|
$86.1M |
Top Sells
| 1 |
ServiceNow
NOW
|
$86.5M |
| 2 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$84.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$73.7M |
| 4 |
Cigna
CI
|
$60.3M |
| 5 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
$48.5M |
Sector Composition
| 1 | Healthcare | 63.46% |
| 2 | Technology | 11.74% |
| 3 | Communication Services | 4.77% |
| 4 | Financials | 3.03% |
| 5 | Consumer Discretionary | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Bristol-Myers Squibb
BMY
$96B
| $198M | 4.01% | +3,123,145 | New | +$198M |
|
|
2
Viatris
VTRS
$12.3B
| $190M | 3.87% | +4,624,079 | New | +$190M |
|
|
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $174M | 3.53% | 5,326,671 -614,384 | -10% | -$20.1M |
|
|
4
Jazz Pharmaceuticals
JAZZ
$7.75B
| $171M | 3.48% | +1,135,527 | New | +$171M |
|
|
AERI
5
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $154M | 3.12% | 2,833,003 +225,792 | +9% | +$12.2M |
|
|
6
Elevance Health
ELV
$71.8B
| $145M | 2.95% | 660,870 +393,065 | +147% | +$86.4M |
|
7
Puma Biotechnology
PBYI
$254M
| $138M | 2.81% | 2,032,619 +210,819 | +12% | +$14.3M |
|
8
Baxter International
BAX
$12.7B
| $134M | 2.73% | 2,067,832 +793,815 | +62% | +$51.6M |
|
9
UnitedHealth
UNH
$281B
| $109M | 2.22% | 511,271 +138,863 | +37% | +$29.7M |
|
10
Abbott
ABT
$231B
| $105M | 2.14% | 1,756,796 +24,254 | +1% | +$1.45M |
|
11
Molina Healthcare
MOH
$9.8B
| $104M | 2.12% | 1,286,398 +111,621 | +10% | +$9.06M |
|
12
Zimmer Biomet
ZBH
$21B
| $97.2M | 1.98% | 891,421 +216,613 | +32% | +$23.6M |
|
13
Microsoft
MSFT
$3.77T
| $96.5M | 1.96% | 1,056,879 +739,938 | +233% | +$67.5M |
|
14
Humana
HUM
$36.5B
| $86.1M | 1.75% | 320,450 +25,970 | +9% | +$6.98M |
|
|
15
Tenet Healthcare
THC
$16.3B
| $86.1M | 1.75% | +3,550,161 | New | +$86.1M |
|
|
BPMC
16
DELISTED
Blueprint Medicines
BPMC
| $84.2M | 1.71% | 917,990 +51,250 | +6% | +$4.7M |
|
17
Revvity
RVTY
$10.5B
| $81.9M | 1.66% | 1,081,507 +183,347 | +20% | +$13.9M |
|
18
Esperion Therapeutics
ESPR
$448M
| $81.7M | 1.66% | 1,129,998 +259,896 | +30% | +$18.8M |
|
19
GoDaddy
GDDY
$20.5B
| $79.8M | 1.62% | 1,299,060 -644,468 | -33% | -$39.6M |
|
|
ACOR
20
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $79.4M | 1.61% | 3,355,184 -96,369 | -3% | -$2.28M |
|
21
Edwards Lifesciences
EW
$47.8B
| $78.1M | 1.59% | 559,995 -333,288 | -37% | -$46.5M |
|
22
Penumbra
PEN
$10.6B
| $74.8M | 1.52% | 646,986 -178,526 | -22% | -$20.6M |
|
|
MDCO
23
DELISTED
Medicines Co
MDCO
| $72.6M | 1.47% | 2,203,331 +358,279 | +19% | +$11.8M |
|
24
PayPal
PYPL
$67.1B
| $67.7M | 1.38% | 892,756 +201,134 | +29% | +$15.3M |
|
25
Salesforce
CRM
$245B
| $64.6M | 1.31% | 555,808 -266,272 | -32% | -$31M |
|